logo

CLOV

Clover Health·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CLOV fundamentals

Clover Health (CLOV) released its earnings on Nov 4, 2025: revenue was 479.10M (YoY +44.75%), beat estimates; EPS was -0.05 (YoY -150.00%), missed estimates.
Revenue / YoY
479.10M
+44.75%
EPS / YoY
-0.05
-150.00%
Report date
Nov 4, 2025
CLOV Earnings Call Summary for Q3,2025
  • Revenue Surge: 35% membership growth to 109,000, revenue up 49% YoY to $479M.
  • Profitability Challenges: $45M adjusted EBITDA (down $17M YoY) due to 44,000 new members and 4% medical cost trend.
  • Star Rating Update: 3.5-star for 2026,4-star target with CMS rate benefits.
  • 2026 Outlook: 90-91% BER, $15-30M EBITDA,2026, 17-18% SG&A leverage.
EPS
Revenue

Revenue & Expenses

CLOV has released its 2025 Q3 earnings report, with revenue of 496.65M, reflecting a YoY change of 50.05%, and net profit of -24.38M, showing a YoY change of -166.27%. The Sankey diagram below clearly presents CLOV's revenue sources and cost distribution.

Key Indicators

Clover Health (CLOV) key financial stats and ratios, covering profitability, financial health, and leverage.
Clover Health (CLOV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Clover Health (CLOV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Clover Health (CLOV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Clover Health (CLOV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Clover Health (CLOV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield